What top creators are saying about Intra-Cellular Therapies, Inc.(ITCI)
Biopharmaceutical company whose schizophrenia drug achieved blockbuster sales.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Intra-Cellular Therapies, Inc..
Top creators covering Intra-Cellular Therapies, Inc. (ITCI)
The 1 sources with the most insights about Intra-Cellular Therapies, Inc. on Kazuha.
Latest insights about Intra-Cellular Therapies, Inc. (ITCI)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
Cited as an example that a drug can achieve substantial sales despite competition in a crowded market; the example was not presented as a recommendation to buy.
Yesterday
Cited as an example that a drug can achieve substantial sales despite competition in a crowded market; the example was not presented as a recommendation to buy.
Discussed alongside Intra-Cellular Therapies, Inc. (ITCI)
Other assets that creators frequently mention in the same content as Intra-Cellular Therapies, Inc..
Frequently asked
Which podcasters and creators cover Intra-Cellular Therapies, Inc. (ITCI) the most?
The most active sources covering Intra-Cellular Therapies, Inc. (ITCI) on Kazuha are @theshkrelipill. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Intra-Cellular Therapies, Inc. (ITCI) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Intra-Cellular Therapies, Inc. (ITCI) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Intra-Cellular Therapies, Inc. (ITCI)?
Creators covering Intra-Cellular Therapies, Inc. (ITCI) most frequently also discuss KOD, N/A, N/A. See the "Discussed alongside" section above for full asset pages.